G.D.O. Lowe

5.4k total citations
61 papers, 1.4k citations indexed

About

G.D.O. Lowe is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, G.D.O. Lowe has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in G.D.O. Lowe's work include Blood properties and coagulation (20 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). G.D.O. Lowe is often cited by papers focused on Blood properties and coagulation (20 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). G.D.O. Lowe collaborates with scholars based in United Kingdom, United States and Australia. G.D.O. Lowe's co-authors include Ann Rumley, F G Dunn, G Y H Lip, C.D. Forbes, A. Rumley, Michael Small, J. W. G. Yarnell, P M Sweetnam, R P Ford and B. McArdle and has published in prestigious journals such as The Lancet, European Heart Journal and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

G.D.O. Lowe

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.D.O. Lowe United Kingdom 17 444 396 365 285 276 61 1.4k
J. Zahavi United Kingdom 19 471 1.1× 214 0.5× 316 0.9× 296 1.0× 333 1.2× 37 1.1k
Anna Maria Cerbone Italy 23 458 1.0× 193 0.5× 679 1.9× 384 1.3× 317 1.1× 56 1.6k
Giuseppe Cella Italy 21 399 0.9× 294 0.7× 533 1.5× 441 1.5× 428 1.6× 87 1.4k
U de Faire Sweden 8 511 1.2× 514 1.3× 487 1.3× 101 0.4× 287 1.0× 15 1.6k
J.C.W. van de Loo Germany 4 594 1.3× 460 1.2× 348 1.0× 152 0.5× 416 1.5× 7 1.6k
Agatina Alessandrello Liotta Italy 17 424 1.0× 199 0.5× 366 1.0× 325 1.1× 224 0.8× 42 1.3k
Shu He Sweden 20 316 0.7× 363 0.9× 555 1.5× 250 0.9× 122 0.4× 42 1.1k
M Bory France 13 899 2.0× 306 0.8× 232 0.6× 203 0.7× 468 1.7× 69 1.5k
D. Tschoepe Germany 19 710 1.6× 185 0.5× 359 1.0× 181 0.6× 315 1.1× 31 1.4k
Alfred Szamosi Sweden 12 702 1.6× 645 1.6× 490 1.3× 105 0.4× 389 1.4× 36 1.9k

Countries citing papers authored by G.D.O. Lowe

Since Specialization
Citations

This map shows the geographic impact of G.D.O. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.D.O. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.D.O. Lowe more than expected).

Fields of papers citing papers by G.D.O. Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.D.O. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.D.O. Lowe. The network helps show where G.D.O. Lowe may publish in the future.

Co-authorship network of co-authors of G.D.O. Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of G.D.O. Lowe. A scholar is included among the top collaborators of G.D.O. Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.D.O. Lowe. G.D.O. Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Neill, Kathleen, Jeanne Jackson, Alex D. McMahon, et al.. (2005). Are Atrial Fibrillation Guidelines Altering Management? A Community Based Study. Scottish Medical Journal. 50(4). 166–169. 7 indexed citations
2.
Lowe, G.D.O., S. Goya Wannamethee, A. G. Shaper, et al.. (2003). The effects of different alcoholic drinks on haemostatic and inflammatory markers, lipids and insulin in older men: British Regional Heart Study. UCL Discovery (University College London). 3 indexed citations
3.
Walker, Isobel D., et al.. (2001). Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2‐year review. Haemophilia. 7(2). 160–163. 33 indexed citations
4.
Lowe, G.D.O., et al.. (2000). Haemostatic factors and risk of varicose veins and chronic venous insufficiency: Edinburgh Vein Study. Blood Coagulation & Fibrinolysis. 11(8). 775–781. 11 indexed citations
5.
Wray, D. Walter, et al.. (1999). Textbook of General and Oral Medicine. UCL Discovery (University College London). 5 indexed citations
6.
Gollmann, Dieter, et al.. (1998). Panel Introduction. 79. 1 indexed citations
7.
Rumley, Ann, G.D.O. Lowe, John Norrie, et al.. (1997). Blood rheology and outcome in the West of Scotland Coronary Prevention Study. Thrombosis and Haemostasis. 10 indexed citations
8.
MacRury, Sandra, S. B. Pinion, John Quin, et al.. (1995). Blood Rheology and Albumin Excretion in Diabetic Pregnancy. Diabetic Medicine. 12(1). 51–55. 3 indexed citations
9.
Ludlam, C A, G.D.O. Lowe, & E. E. Mayne. (1995). A pharmacokinetic study of an ion‐exchange solvent—detergent‐treated high‐purity factor VIII concentrate. Transfusion Medicine. 5(4). 289–292. 2 indexed citations
10.
Leng, G.C., F.B. Smith, F.G.R. Fowkes, et al.. (1994). Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukotrienes and Essential Fatty Acids. 51(2). 101–108. 37 indexed citations
11.
Sundaram, S., J.M. Courtney, David P. Taggart, et al.. (1994). Biocompatibility of Cardiopulmonary Bypass: Influence on Blood Compatibility of Device Type, Mode of Blood Flow and Duration of Application. The International Journal of Artificial Organs. 17(2). 118–128. 13 indexed citations
12.
Drost, Ellen, C. Selby, S Lannan, G.D.O. Lowe, & William MacNee. (1992). Changes in Neutrophil Deformability following In Vitro Smoke Exposure: Mechanism and Protection. American Journal of Respiratory Cell and Molecular Biology. 6(3). 287–295. 53 indexed citations
13.
MacRury, Sandra, John C. Lockhart, Michael Small, et al.. (1991). Do Rheological Variables Play a Role in Diabetic Peripheral Neuropathy?. Diabetic Medicine. 8(3). 232–236. 16 indexed citations
14.
Lowe, G.D.O.. (1990). Drugs in cerebral and peripheral arterial disease.. BMJ. 300(6723). 524–528. 14 indexed citations
15.
Belch, J. J. F., et al.. (1990). Further Evidence that the Residual vWf:Ag in Porcine FVIIL·C Induces Human Platelet Aggregation. Pathophysiology of Haemostasis and Thrombosis. 20(5). 289–295. 3 indexed citations
16.
Small, Michael, et al.. (1987). The Effect of Exercise on Thrombin and Plasmin Generation in Middle-Aged Men. Pathophysiology of Haemostasis and Thrombosis. 17(6). 371–376. 7 indexed citations
17.
Greer, Ian A., et al.. (1985). Haematuria in patients with haemostatic defects.. BMJ. 290(6482). 1648–1649. 1 indexed citations
18.
Small, Michael, G.D.O. Lowe, G. H. Beastall, et al.. (1985). Serum Oestradiol and Ischaemic Heart Disease - Relationship with Myocardial Infarction but not Coronary Atheroma or Haemostasis. QJM. 57(223). 775–82. 28 indexed citations
19.
Small, Michael, A. C. Tweddel, Andrew Rankin, et al.. (1984). Blood Coagulation and Platelet Function following Maximal Exercise: Effects of Beta-Adrenoceptor Blockade. Pathophysiology of Haemostasis and Thrombosis. 14(3). 262–268. 31 indexed citations
20.
Lowe, G.D.O., C.D. Forbes, C. R. M. Prentice, & J.C. Barbenel. (1977). Thromboembolic Prophylaxis and Viscosity Reduction with Ancrod. Thrombosis and Haemostasis. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026